3 results on '"Yongcheng Hu"'
Search Results
2. Mid-term results of giant cell tumours with pathologic fractures around the knee: a multicentre retrospective study
- Author
-
Liming, Zhao, Jiapei, Chen, Yongcheng, Hu, Zhaoming, Ye, and Kun, Tao
- Subjects
Adult ,Giant Cell Tumor of Bone ,Adolescent ,Bone Neoplasms ,Middle Aged ,Young Adult ,Fractures, Spontaneous ,Treatment Outcome ,Rheumatology ,Humans ,Orthopedics and Sports Medicine ,Neoplasm Recurrence, Local ,Aged ,Retrospective Studies - Abstract
Objective The aims of this work are to present a classification of “complex fracture” and “simple fracture”, to compare their features, treatments and prognosis in patients with giant cell tumour with pathologic fractures around the knee, and to determine the best surgical method for patients who have giant cell tumour around the knee with different degrees of fracture. Methods Data from 130 patients with pathologic fractures from giant cell tumour around the knee who underwent surgical treatment from March 2000 to November 2015 at 6 institutes around China were collected and analysed. A multicentric study design was used to explore the epidemiological features and to compare differences in the surgical procedures and prognosis of the two fracture groups. The mean age at diagnosis was 37.1 years old (range, 13-77 years). The median follow-up was 126.5 months, ranging from 68 to 370 months. Results The general clinical and imaging features of the groups of patients with simple and complex fractures, namely, sex, age, the lesion site, living or working environment, eccentric growth patterns, Campanacci grading system, and duration of symptoms before treatment, showed varying degrees of differences, but with no statistical significance (p > 0.05). The incidence rate of surrounding soft tissue mass was 35.2% (32/91) in the group with simple fractures, whereas it was 87.2% (34/39) in the group with complex fractures, which showed a significant difference (p < 0.05). Wide resection and reconstruction with joint replacement were performed more often in patients with complex fractures (61.5%, 24/39). Intralesional procedures were performed more often in patients with simple fractures (56.0%, 51/91). The difference showed significant differences (p < 0.05). The local recurrence rate was 17.6% (16/91) in the group with simple fractures, whereas it was 10.3% (4/39) in the complex fracture group, showing a significant difference (p < 0.05). A total of 2.3% of patients (n = 3,3/130) developed a skip lesion. The complication rates were 4.6% (4/87) and 14.7% (5/34), respectively, in the two groups with simple or complex fractures, showing a significant difference (p < 0.05). The mean MSTS and TESS scores with simple fractures were 26.6 (range, 13–30) and 84.1 (range, 29-100), respectively, whereas the mean scores in the group with complex fractures were 25.5 (range, 18–30) and 78.3 (range, 30-100), respectively, also showing a significant difference (p < 0.05). Conclusion Our classification of “simple fracture” and “complex fracture” could guide decisions regarding the best surgical method for lesions in patients who have giant cell tumour around the knee with different degrees of fracture.
- Published
- 2022
3. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively
- Author
-
Zhi Yao, Kai Zhang, Zha la Ga hu, Zhenyi Xue, Xixi Cheng, Huan Zhang, Ning Zhang, Liang Qiao, Yongcheng Hu, Dan Wang, Wenjing Huang, Fei Gao, Rongxin Zhang, Yurong Da, Huafeng Wang, and Biao Huang
- Subjects
Liver Cirrhosis ,0301 basic medicine ,Down-Regulation ,Apoptosis ,Inflammation ,Mesenchymal Stem Cell Transplantation ,MSC-CM ,General Biochemistry, Genetics and Molecular Biology ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Fulminant hepatic failure ,Hepatic stellate cells ,Animals ,Regeneration ,Medicine ,Macrophage ,Carbon Tetrachloride ,Cell Proliferation ,Medicine(all) ,Mice, Inbred ICR ,Biochemistry, Genetics and Molecular Biology(all) ,business.industry ,Macrophages ,Research ,Mesenchymal stem cell ,Liver failure ,Mesenchymal Stem Cells ,General Medicine ,Liver Failure, Acute ,Survival Analysis ,CD4+ T cells ,Liver regeneration ,Mice, Inbred C57BL ,RAW 264.7 Cells ,030104 developmental biology ,medicine.anatomical_structure ,Liver ,Culture Media, Conditioned ,030220 oncology & carcinogenesis ,Hepatocyte ,Chronic Disease ,Cancer research ,Hepatic stellate cell ,Female ,medicine.symptom ,business - Abstract
Background Orthotopic liver transplantation is the only effective treatment for liver failure but limited with shortage of available donor organs. Recent studies show promising results of mesenchymal stem cells (MSCs)-based therapies. Methods We systematically investigate the therapeutic effects of MSCs or MSC-conditioned medium (MSC-CM) in ameliorating fulminant hepatic failure (FHF) and chronic liver fibrosis in mice. In addition, extensive flow cytometry analysis of spleens from vehicle and MSC- and MSC-CM-treated mice was applied to reveal the alteration of inflammatory state. Results In FHF model, MSCs treatment reduced remarkably the death incidents; the analysis of gross histopathology showed that control livers were soft and shrunken with extensive extravasated blood, which was gradually reduced at later time points, while MSC–treated livers showed gross pathological changes, even 24 h after MSC infusion, and hematoxylin and eosin staining revealed dramatical hepatocellular death with cytoplasmic vacuolization suppressed by MSCs treatment; flow cytometry analysis of total lymphocytes showed that macrophages (F4/80) infiltrated into control livers more than MSC-treated livers; by contrast, MSC-CM partially ameliorates FHF. In chronic liver injury model, MSC and MSC-CM both suppressed fibrogenesis and necroinflammatory, and the later was better; activation of hepatic stellate cells (α-SMA) was inhibited; glycogen synthesis and storage (indicated by periodic acid-Schiff -staining) was improved; liver regeneration (Ki67) was promoted while liver apoptosis (TUNEL) was reduced. In the in vitro, MSCs promote macrophage line RAW264.7 apoptosis and MSC-CM promotes apoptosis and inhibits proliferation of HSC line LX-2. We also found that MSCs and MSC-CM could improve spleen; MSC-CM increased levels of Th2 and Treg cells, and reduced levels of Th17 cells, whereas levels of Th1 cells were unchanged; comparatively, MSC treatment did not affect Th17 and Treg cells and only slightly alters inflammatory state; MSC and MSC-CM treatment both substantially down-regulated macrophages in the spleens. Conclusion Both MSCs and MSC-CM exert therapeutic effects by acting on various key cells during the pathogenesis of FHF and chronic fibrosis, stimulating hepatocyte proliferation and suppressing apoptosis, down-regulating infiltrating macrophages, converting CD4+ T lymphocyte system into an anti-inflammatory state, and facilitating hepatic stellate cell death. Electronic supplementary material The online version of this article (doi:10.1186/s12967-016-0792-1) contains supplementary material, which is available to authorized users.
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.